drug
IMG-007
Phase 2updated 3mo agoby $IMA ImageneBio, Inc.
Phase 2community read0 votes
all catalysts(0)
nothing on the calendar yet
Trials studying IMG-007
- phase2Long-term Safety and Efficacy Evaluation of IMG-007 in Participants With Moderate-to-Severe Atopic Dermatitis
- phase2A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis
- phase2A Study to Evaluate the Safety, Pharmacokinetics and Efficacy of IMG-007 in Adult Alopecia Areata Participants
- phase2A Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of IMG-007 in Adults With Atopic Dermatitis (AD)
- phase1Safety and Pharmacokinetics of Subcutaneous Dose of IMG-007 in Healthy Participants
- phase1Evaluate IMG-007 in Healthy Participants
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 16m ago
Found something off?
comments(0)
5-min edit window · permanent after that